Efficacy and safety of intravenous ferric Carboxy maltose in iron deficiency anemia During post-partum period

Abstract

OBJECTIVE : To study efficacy and safety of ferric carboxy maltose (FCM) in postpartum anemia correction. MATERIALS AND METHODOLOGY: A prospective observational study done between january to june 2021 at a tertiary health care center, Belagavi, Karnataka. In this study, 90 postpartum women with diagnosis of iron deficiency anemia with hemoglobin ranging between 7 gm% to 11 gm% were included. Women included under study were evaluated for hemoglobin levels, peripheral smear and serum ferritin levels 12 hours after the delivery followed by which injection ferric carboxy maltose (FCM) was given. The drug administration was done under supervision and observed for adverse effects. Women were followed up after three weeks of injection FCM and checked for improvement in hemoglobin levels.